Dana reports 2025 adjusted EBITDA of $610 million, up from $395 million
Dana reported full-year 2025 sales of $7.5 billion, down from $7.7 billion in 2024, while adjusted EBITDA rose to $610 million from $395 million on cost savings. The company confirmed its 2026 outlook and increased its capital return authorization from $1 billion to $2 billion, which matters to shareholders because it expands the company's planned share repurchases.
Key points
- Full-year 2025 sales were $7.5 billion, compared with $7.7 billion in 2024; adjusted EBITDA margin was 8.1%, compared with 5.1%.
- Adjusted free cash flow for 2025 was $331 million, compared with $81 million in 2024.
- 2026 preliminary guidance: sales of $7.30 to $7.70 billion, adjusted EBITDA of $750 to $850 million, and diluted adjusted EPS of $2.00 to $3.00.
- Capital return authorization increased from $1 billion to $2 billion; the company will host a Capital Markets Day on March 25, 2026.
The filing
Written by AI on Nov 8, 2026, 6:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 18, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.